Oncoclínicas do Brasil Serviços Médicos S.A. provides healthcare services focused on oncology, hematology, and radiotherapy in Latin America. It offers diagnosis and treatment services, such as pathological analysis, cryotherapy, palliative care, delife, hilotherapy, molecular journey, laser therapy, integrative medicine, myelogram-bone marrow biopsy, OC care line, OC precision medicine, oncoACCESS, survivorship, telemedicine, genetic testing, personalized medicine and individualized treatment, and veinviewer. The company also provides services in the areas of chemotherapy, hormone therapy, molecular target drugs, immunotherapy, bone marrow transplant, catheter salinization and heparinization, and non-oncological infusions. It has collaboration with MGI Tech Co., Ltd. to accelerates the laboratory advancements in genomic medicine. The company was founded in 2010 and is based in São Paulo, Brazil.
Metrics to compare | ONCO3 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipONCO3PeersSector | |
---|---|---|---|---|
P/E Ratio | 47.2x | −0.9x | −0.5x | |
PEG Ratio | −0.70 | 0.15 | 0.00 | |
Price/Book | 0.9x | 0.8x | 2.6x | |
Price / LTM Sales | 0.6x | 0.7x | 3.0x | |
Upside (Analyst Target) | 6.5% | 37.9% | 55.6% | |
Fair Value Upside | Unlock | 35.0% | 10.1% | Unlock |